VIDIA
MONO-VIDITEST anti-Borrelia recombinant IgM
REF KZ-301-12 · Mono-cassette · 12 tests · IgM antibodies
Popis
MONO-VIDITEST anti-Borrelia recombinant IgM - Cassette mono-test intended for semiquantitative and quantitative determination of IgM antibodies against pathogenic Borrelia strains (B. afzelii, B. garinii, B. burgdorferi s.s. and B. spielmanii) in human serum, plasma, cerebrospinal fluid and synovial fluid, and for estimation of intrathecal antibody production. The test is used in the diagnosis of early stages of Lyme borreliosis, including erythema migrans, lymphocytoma and early neuroborreliosis. IgM antibodies are detectable approximately 3 weeks after infection, peak around week 6, and then decrease as IgG antibodies develop. The Antibody Index (AI) can be determined for CSF. The kit is intended for professional use.
Parametry soupravy
- REF
- KZ-301-12
- Pathogen
- Borrelia
- Detected marker
- IgM antibodies
- Method
- MONO
- Format
- Mono-cassette
- Number of tests
- 12 tests
- Sample type
- Serum / Plasma / Cerebrospinal fluid (CSF) / Synovial fluid
- Evaluation
- Qualitative, Semiquantitative, Quantitative
- Testing option
- Intrathecal synthesis
- Incubation
- 30 min (37°) / 30 min (37°) / 15 min (RT)
- Product line
- MONO-VIDITEST
Obsah soupravy
- MONO-VIDITEST cassettes with RF sorbent
- STOP solution
- Instructions for use
- Quality control certificate
